mFOLFIRINOX trials for PDAC - Pancreatic Ductal Adenocarcinoma

All mFOLFIRINOX trials · All PDAC - Pancreatic Ductal Adenocarcinoma trials

Phase breakdown

Recruiting trials studying mFOLFIRINOX for PDAC - Pancreatic Ductal Adenocarcinoma

• A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
  NCT06835569 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• BBO-11818 in Adult Subjects With KRAS Mutant Cancer
  NCT06917079 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
  NCT06922591 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations

Common questions

How many trials study mFOLFIRINOX for PDAC - Pancreatic Ductal Adenocarcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.